Evidence map›Paper›PMID 27275396›Full record

ArticleCell death discovery2016

Loss of function of

L Buret, G Rebillard, E Brun, C Angebault, M Pequignot, M Lenoir, M Do-Cruzeiro, E Tournier, K Cornille, A Saleur and 18 more

Open access · goldAbstract read
In one paragraph

Article in Cell death discovery, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed, 1 pooled it
1.0field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 1 synthesis or guideline pooled it, 14 citations in OpenAlex.

  1. A Systematic Review of Genes Affecting Endocochlear Potential.Journal of the Association for Research in Otolaryngology : JARO · 2026
    Pooled it
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

28 authors at 14 institutions in 4 countries.

L BuretINSERM U1051, Institute of Neurosciences of Montpellier, Montpellier, France; Department of Biology and Health Sciences, University of Montpellier, Montpellier, France.
G RebillardINSERM U1051, Institute of Neurosciences of Montpellier, Montpellier, France; Department of Biology and Health Sciences, University of Montpellier, Montpellier, France.
E BrunINSERM U1051, Institute of Neurosciences of Montpellier, Montpellier, France; Department of Biology and Health Sciences, University of Montpellier, Montpellier, France.
C AngebaultINSERM U1051, Institute of Neurosciences of Montpellier, Montpellier, France; Department of Biology and Health Sciences, University of Montpellier, Montpellier, France.
M PequignotINSERM U1051, Institute of Neurosciences of Montpellier, Montpellier, France; Department of Biology and Health Sciences, University of Montpellier, Montpellier, France.
M LenoirINSERM U1051, Institute of Neurosciences of Montpellier, Montpellier, France; Department of Biology and Health Sciences, University of Montpellier, Montpellier, France.
M Do-CruzeiroHomologuous Recombination, Cochin Institute, University Paris Descartes, Paris, France.
E TournierHomologuous Recombination, Cochin Institute, University Paris Descartes, Paris, France.
K CornilleINSERM U1051, Institute of Neurosciences of Montpellier, Montpellier, France; Department of Biology and Health Sciences, University of Montpellier, Montpellier, France.
A SaleurINSERM U1051, Institute of Neurosciences of Montpellier, Montpellier, France; Department of Biology and Health Sciences, University of Montpellier, Montpellier, France.
N GueguenDepartment of Ophthalmology, Angers University Hospital, Angers, France.
P ReynierDepartment of Ophthalmology, Angers University Hospital, Angers, France.
P Amati-BonneauDepartment of Ophthalmology, Angers University Hospital, Angers, France.
A BarakatLaboratory of Human Genetic and Molecular Biology, Pasteur Institute, Casablanca, Morocco.
C BlanchetCHRU Montpellier, Centre of Reference for Genetic Sensory Diseases, CHU, Gui de Chauliac Hospital, Montpellier, France.
P ChinneryMitochondrial Research Group, Institute of Ageing and Health, The Medical School, Newcastle University, Newcastle, UK.
P Yu-Wai-ManMitochondrial Research Group, Institute of Ageing and Health, The Medical School, Newcastle University, Newcastle, UK.
J KaplanLaboratory of Genetics in Ophthalmology, Inserm UMR1163, Institut Imagine, Université Paris Descartes Sorbonne Paris Cité, Hôpital Necker, Paris, France.
A-F RouxLaboratory of Molecular Genetic, CHU Arnaud de Villeneuve, Montpellier, France.
G Van CampCenter of Medical Genetics, Department of Biomedical Sciences, University of Antwerp, Antwerp, Belgium.
B WissingerMolecular Genetics Laboratory, Institute for Ophthalmic Research, Tuebingen, Germany.
O Boespflug-TanguyNeurobiology and Metabolic Diseases, Hospital Robert Debré, Paris, France.
F GiraudetLaboratory of Neurosensorial Biophysic, UMR INSERM 1107, Faculty of Medicine - Auvergne University, Clermont Ferrand, France.
J-L PuelINSERM U1051, Institute of Neurosciences of Montpellier, Montpellier, France; Department of Biology and Health Sciences, University of Montpellier, Montpellier, France.
G LenaersINSERM U1051, Institute of Neurosciences of Montpellier, Montpellier, France; Department of Biology and Health Sciences, University of Montpellier, Montpellier, France.
C HamelINSERM U1051, Institute of Neurosciences of Montpellier, Montpellier, France; Department of Biology and Health Sciences, University of Montpellier, Montpellier, France; CHRU Montpellier, Centre of Reference for Genetic Sensory Diseases, CHU, Gui de Chauliac Hospital, Montpellier, France.
B DelpratINSERM U1051, Institute of Neurosciences of Montpellier, Montpellier, France; Department of Biology and Health Sciences, University of Montpellier, Montpellier, France.
C DelettreINSERM U1051, Institute of Neurosciences of Montpellier, Montpellier, France; Department of Biology and Health Sciences, University of Montpellier, Montpellier, France.
Université de Montpellier · FRInserm · FRUniversité d'Angers · FRInstitute for Neurosciences of Montpellier · FRNewcastle University · GBHôpital Arnaud de Villeneuve · FRHôpital Gui de Chauliac · FRHôpital Robert-Debré · FRInstitut Cochin · FRInstitut Pasteur du Maroc · MASorbonne Paris Cité · FRUniversité Clermont Auvergne · FRUniversité Paris Cité · FRUniversity of Antwerp · BE

Funding

Medical Research Council G0701386Medical Research Council G1002570
6 · The paper itself

Abstract

In vertebrates, 14-3-3 proteins form a family of seven highly conserved isoforms with chaperone activity, which bind phosphorylated substrates mostly involved in regulatory and checkpoint pathways. 14-3-3 proteins are the most abundant protein in the brain and are abundantly found in the cerebrospinal fluid in neurodegenerative diseases, suggesting a critical role in neuron physiology and death. Here we show that 14-3-3eta-deficient mice displayed auditory impairment accompanied by cochlear hair cells' degeneration. We show that 14-3-3eta is highly expressed in the outer and inner hair cells, spiral ganglion neurons of cochlea and retinal ganglion cells. Screening of

Identifiers

PMID27275396
PMCPMC4893315
OpenAlexW2339487094

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.